Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent
- PMID: 4276573
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent
Similar articles
-
Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].Br J Pharmacol. 1977 Mar;59(3):464P-465P. Br J Pharmacol. 1977. PMID: 843708 Free PMC article. No abstract available.
-
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.Br J Pharmacol. 1973 Mar;47(3):658P-659P. Br J Pharmacol. 1973. PMID: 4738385 Free PMC article. No abstract available.
-
Behavioral correlates of dopaminergic supersensitivity.Adv Neurol. 1975;9:81-92. Adv Neurol. 1975. PMID: 1170717 No abstract available.
-
Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.Life Sci. 1980 Oct 6;27(14):1237-53. doi: 10.1016/0024-3205(80)90217-9. Life Sci. 1980. PMID: 6255271 Review. No abstract available.
-
Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.Fed Proc. 1978 Jun;37(8):2181-91. Fed Proc. 1978. PMID: 350633 Review.
Cited by
-
The influence of bromocriptine on serotonin neurons.J Neural Transm. 1977;41(4):253-64. doi: 10.1007/BF01252020. J Neural Transm. 1977. PMID: 925686
-
The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.Psychopharmacology (Berl). 1983;80(1):38-42. doi: 10.1007/BF00427492. Psychopharmacology (Berl). 1983. PMID: 6408668
-
Subchronic Oral Bromocriptine Methanesulfonate Enhances Open Field Novelty-Induced Behavior and Spatial Memory in Male Swiss Albino Mice.Neurosci J. 2013;2013:948241. doi: 10.1155/2013/948241. Epub 2012 Dec 6. Neurosci J. 2013. PMID: 26317106 Free PMC article.
-
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.Br J Clin Pharmacol. 1978 Oct;6(4):303-9. doi: 10.1111/j.1365-2125.1978.tb00856.x. Br J Clin Pharmacol. 1978. PMID: 359016 Free PMC article. Clinical Trial.
-
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.Br J Pharmacol. 1976 Jan;56(1):59-68. doi: 10.1111/j.1476-5381.1976.tb06959.x. Br J Pharmacol. 1976. PMID: 943193 Free PMC article.